In the clinical context, the TRAP assay holds significant potential for:
- Early Detection: By identifying telomerase activity in bodily fluids, the TRAP assay could aid in the early detection of cancer. - Prognosis: Levels of telomerase activity can provide prognostic information, helping to predict disease outcome. - Therapeutic Monitoring: The assay can be used to monitor the effectiveness of telomerase inhibitors and other treatments in clinical trials.